Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07668102 · ClinicalTrials.gov registry record · NA
Visual Performance of Highly Aspherical Lenslet Spectacles in Children (Ancillary to WS10246)
A NA study, sponsored by Essilor International.
- Completed
- Registry status
- NA
- Development phase
- 88
- Enrollment target
NCT07668102: Completed NA study, sponsored by Essilor International.
NCT07668102 is a NA study that has completed, run by Essilor International. The registered enrollment target is 88 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07668102, a NA study, has completed, sponsored by Essilor International.
- COMPLETED
- Registry status
- NA
- Development phase
- 88 participants
- Enrollment target
Study Summary
To evaluate the visual performance of (high and low contrast distance visual acuity, reading speed, near visual acuity, and near contrast sensitivity) of HAL spectacle lenses (habitual correction) in comparison with single vision control lenses.
Primary Outcome
Reading speed (mean words per minute) collected using the Wolffsohn Research iPad OptomCentral App
Interventions
- DEVICE HAL spectacle lens
- DEVICE Single Vision spectacle lens
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2024-05-22 |
| Est. Completion | 2024-10-20 |
| Phase | NA |
What the finished NCT07668102 record still lists
NCT07668102 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 88 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 2 interventions - of which HAL spectacle lens is the first listed.
NCT07668102 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07668102 about?
NCT07668102 is a clinical study titled "Visual Performance of Highly Aspherical Lenslet Spectacles in Children (Ancillary to WS10246)". To evaluate the visual performance of (high and low contrast distance visual acuity, reading speed, near visual acuity, and near contrast sensitivity) of HAL spectacle lenses (habitual correction) in comparison with single vision control lenses.
What is the current status of trial NCT07668102?
This trial is currently completed. It is a NA study. The enrollment target is 88 participants. The study started on 2024-05-22. Estimated completion is 2024-10-20.
What interventions are being tested in trial NCT07668102?
The interventions under investigation include: HAL spectacle lens (DEVICE), Single Vision spectacle lens (DEVICE).
Who is sponsoring clinical trial NCT07668102?
This trial is sponsored by Essilor International, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07668102's enrollment target sits among peer trials
88 972nd of 2000 higher than 1,027 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03843463 · 88 participants · Phase 2
Escitalopram and Language Intervention for Subacute Aphasia
- NCT04066348 · 88 participants · Phase 2
TNF-α Treatment of Blast-Induced Tinnitus
- NCT04331704 · 88 participants · Phase 4
ANCHORS Alcohol & Sexual Health Study: UH3 Project
- NCT04536103 · 88 participants
Multi-Vendor Multi-Site Novel Accelerated MRI Relaxometry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI